2-(2,6-dimethyl-8-pentan-3-ylimidazo[1,2-b]pyridazin-3-yl)-5-(2-methyl-1,5-dihydro-1,2,4-triazol-3-yl)thiophene-3-carbonitrile

C21H25N7S — CID 68841697

IUPAC2-(2,6-dimethyl-8-pentan-3-ylimidazo[1,2-b]pyridazin-3-yl)-5-(2-methyl-1,5-dihydro-1,2,4-triazol-3-yl)thiophene-3-carbonitrile
SMILESCCC(CC)c1cc(C)nn2c(-c3sc(C4=NCNN4C)cc3C#N)c(C)nc12
InChIInChI=1S/C21H25N7S/c1-6-14(7-2)16-8-12(3)26-28-18(13(4)25-20(16)28)19-15(10-22)9-17(29-19)21-23-11-24-27(21)5/h8-9,14,24H,6-7,11H2,1-5H3
InChIKeyXICAWMICXHEUJK-UHFFFAOYSA-N
MW407.55 g/mol
LogP4.00
Rot. Bonds5

About 2-(2,6-dimethyl-8-pentan-3-ylimidazo[1,2-b]pyridazin-3-yl)-5-(2-methyl-1,5-dihydro-1,2,4-triazol-3-yl)thiophene-3-carbonitrile

2-(2,6-dimethyl-8-pentan-3-ylimidazo[1,2-b]pyridazin-3-yl)-5-(2-methyl-1,5-dihydro-1,2,4-triazol-3-yl)thiophene-3-carbonitrile (PubChem CID 68841697) has the molecular formula C21H25N7S and a molecular weight of 407.55 g/mol. Its IUPAC name is 2-(2,6-dimethyl-8-pentan-3-ylimidazo[1,2-b]pyridazin-3-yl)-5-(2-methyl-1,5-dihydro-1,2,4-triazol-3-yl)thiophene-3-carbonitrile.

Molecular Properties

Compound Name2-(2,6-dimethyl-8-pentan-3-ylimidazo[1,2-b]pyridazin-3-yl)-5-(2-methyl-1,5-dihydro-1,2,4-triazol-3-yl)thiophene-3-carbonitrile
PubChem CID68841697
Molecular FormulaC21H25N7S
Molecular Weight407.55 g/mol
Exact Mass407.19
IUPAC Name2-(2,6-dimethyl-8-pentan-3-ylimidazo[1,2-b]pyridazin-3-yl)-5-(2-methyl-1,5-dihydro-1,2,4-triazol-3-yl)thiophene-3-carbonitrile
SMILESCCC(CC)c1cc(C)nn2c(-c3sc(C4=NCNN4C)cc3C#N)c(C)nc12
InChIInChI=1S/C21H25N7S/c1-6-14(7-2)16-8-12(3)26-28-18(13(4)25-20(16)28)19-15(10-22)9-17(29-19)21-23-11-24-27(21)5/h8-9,14,24H,6-7,11H2,1-5H3
InChIKeyXICAWMICXHEUJK-UHFFFAOYSA-N
XLogP4.00
TPSA81.61 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds5
Heavy Atoms29
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500407.55
LogP ≤ 54.00
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Analyze 2-(2,6-dimethyl-8-pentan-3-ylimidazo[1,2-b]pyridazin-3-yl)-5-(2-methyl-1,5-dihydro-1,2,4-triazol-3-yl)thiophene-3-carbonitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-(2,6-dimethyl-8-pentan-3-ylimidazo[1,2-b]pyridazin-3-yl)-5-(2-methyl-1,5-dihydro-1,2,4-triazol-3-yl)thiophene-3-carbonitrile?
The IUPAC name of 2-(2,6-dimethyl-8-pentan-3-ylimidazo[1,2-b]pyridazin-3-yl)-5-(2-methyl-1,5-dihydro-1,2,4-triazol-3-yl)thiophene-3-carbonitrile (CID 68841697) is 2-(2,6-dimethyl-8-pentan-3-ylimidazo[1,2-b]pyridazin-3-yl)-5-(2-methyl-1,5-dihydro-1,2,4-triazol-3-yl)thiophene-3-carbonitrile.
What is the SMILES notation for 2-(2,6-dimethyl-8-pentan-3-ylimidazo[1,2-b]pyridazin-3-yl)-5-(2-methyl-1,5-dihydro-1,2,4-triazol-3-yl)thiophene-3-carbonitrile?
The canonical SMILES for 2-(2,6-dimethyl-8-pentan-3-ylimidazo[1,2-b]pyridazin-3-yl)-5-(2-methyl-1,5-dihydro-1,2,4-triazol-3-yl)thiophene-3-carbonitrile is CCC(CC)c1cc(C)nn2c(-c3sc(C4=NCNN4C)cc3C#N)c(C)nc12.
What is the InChIKey of 2-(2,6-dimethyl-8-pentan-3-ylimidazo[1,2-b]pyridazin-3-yl)-5-(2-methyl-1,5-dihydro-1,2,4-triazol-3-yl)thiophene-3-carbonitrile?
The InChIKey is XICAWMICXHEUJK-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H25N7S/c1-6-14(7-2)16-8-12(3)26-28-18(13(4)25-20(16)28)19-15(10-22)9-17(29-19)21-23-11-24-27(21)5/h8-9,14,24H,6-7,11H2,1-5H3.
What are the key properties of 2-(2,6-dimethyl-8-pentan-3-ylimidazo[1,2-b]pyridazin-3-yl)-5-(2-methyl-1,5-dihydro-1,2,4-triazol-3-yl)thiophene-3-carbonitrile?
2-(2,6-dimethyl-8-pentan-3-ylimidazo[1,2-b]pyridazin-3-yl)-5-(2-methyl-1,5-dihydro-1,2,4-triazol-3-yl)thiophene-3-carbonitrile has a molecular weight of 407.55 g/mol, XLogP of 4.00, 5 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(2,6-dimethyl-8-pentan-3-ylimidazo[1,2-b]pyridazin-3-yl)-5-(2-methyl-1,5-dihydro-1,2,4-triazol-3-yl)thiophene-3-carbonitrile is sourced from PubChem (CID 68841697), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).